| Literature DB >> 21992554 |
Andrea Hinsch1, Eik Vettorazzi, Michael M Morlock, Wolfgang Rüther, Michael Amling, Jozef Zustin.
Abstract
BACKGROUND: Metal-on-metal hybrid hip resurfacing arthroplasty (with a cementless acetabular component and a cemented femoral component) is offered as an alternative to traditional total hip arthroplasty for the young and active adult with advanced osteoarthritis. Although it has been suggested that women are less appropriate candidates for metal-on-metal arthroplasty, the mechanisms of prosthesis failure has not been fully explained. While specific failure patterns, particularly osteonecrosis and delayed type hypersensitivity reactions have been suggested to be specifically linked to the sex of the patient, we wished to examine the potential influence of sex, clinical diagnosis, age of the patient and the size of the femoral component on morphological failure patterns in a large cohort of retrieved specimens following aseptic failure of hip resurfacing arthroplasty.Entities:
Mesh:
Year: 2011 PMID: 21992554 PMCID: PMC3204242 DOI: 10.1186/1741-7015-9-113
Source DB: PubMed Journal: BMC Med ISSN: 1741-7015 Impact factor: 8.775
Cases not included in the present study
| reason for | men | women |
|---|---|---|
| bone tissue absent | n = 7 | n = 13 |
| (n = 46) | 59, 55 to 69 | 62, 58 to 65 |
| bone tissue severely damaged | n = 3 | n = 2 |
| (n = 16) | 57,56 to 66 | 53, 53 |
| bone tissue sent without fixation | n = 0 | n = 5 |
| (n = 11) | 56, 40 to 63 | |
| periprosthetic infection | n = 3 | n = 2 |
| (n = 6) | 48, 38 to 58 | 47, 65 |
| total | n = 13 | n = 22 |
| (n = 79) | 57, 54 to 65 | 59, 53 to 64 |
Demographic and clinical characteristics of the study cohort
| entire study cohort | entire study cohort | valid data on sex | ||||
|---|---|---|---|---|---|---|
| unknown sex | valid data on sex | men | women | |||
| age | 56, | 51, | 56, | 56, | 56, | |
| clinical diagnosis | osteoarthritis | 107 | 5 | 102 | 54 | 48 |
| avascular | 10 | 0 | 10 | 8 | 2 | |
| rheumatoid arthritis | 7 | 0 | 7 | 3 | 4 | |
| arthritis secondary | 7 | 0 | 7 | 3 | 4 | |
| developmental | 17 | 1 | 16 | 6 | 10 | |
| THRA design | ASR™ | 143 | 18 | 125 | 66 | 59 |
| DUROM® | 16 | 1 | 15 | 8 | 7 | |
| Cormet™ | 20 | 6 | 14 | 6 | 8 | |
| BHR™ | 14 | 4 | 10 | 4 | 6 | |
| ReCAP® | 11 | 2 | 9 | 4 | 5 | |
| duration of implantation | 147, | 127, | 147, | 124, | 182, | |
| size of the femoral component | 46, | 46, | 46, | 50, | 44, | |
The prevalence of distinct failure patterns in the study cohort
| entire study cohort | entire study cohort | valid data on sex | ||||
|---|---|---|---|---|---|---|
| unknown sex | valid data on sex | men | women | |||
| cause for revision | periprosthetic fracture | 133 | 19 | 114 | 65 | 49 |
| non-fractural cause | 71 | 12 | 59 | 23 | 36 | |
| periprosthetic fracture | postnecrotic | 73 | 9 | 64 | 41 | 23 |
| osteonecrosis | present | 174 | 23 | 151 | 80 | 71 |
| absent | 30 | 8 | 22 | 8 | 14 | |
| extent of osteonecrosis | 7.4, | 6.4, | 7.6, | 15.3, | 6.2, | |
| 2.9 to | 2.1 to | 3.1 to | 3.6 to | 2.6 to | ||
| non-fractural causes | Loosening of the | 15 | 1 | 14 | 4 | 10 |
| Loosening of the | 10 | 3 | 7 | 2 | 5 | |
| cement-socket | 3 | 0 | 3 | 2 | 1 | |
| Collapsed | 5 | 2 | 3 | 0 | 3 | |
| Metallosis | 2 | 1 | 1 | 0 | 1 | |
| Unexplained | 36 | 5 | 31 | 14 | 17 | |
| unexplained | excessive lymphocyte | 14 | 3 | 11 | 1 | 10 |
| interface hyperosteoidosis | 37 | 7 | 30 | 8 | 22 | |
Figure 1Morphological findings in retrieved hip resurfacing arthroplasty. (A) Callus formation in chronic fracture. (B) Osteonecrosis (above) with bordering sclerosis (mid) and adjacent viable fatty bone marrow (lower) distal from the osteonecrotic lesion. (C) Excessive intraosseous lymphocyte infiltration in the vicinity of the bone-cement interface (above). (D) Hyperosteoidosis of bone trabecula at the bone-cement interface (above). (A-D: stain: Goldner trichrome, original magnification: ×200).
Periprosthetic fractures in the cohort of retrieved hip resurfacing arthroplasty
| OR | 95% CI for OR | Significance | ||
|---|---|---|---|---|
| Lower | Upper | ( | ||
| Sex (female) | 0.482 | 0.254 | 0.915 | 0.026 |
| Size of the Femoral Component | 1.031 | 0.959 | 1.109 | 0.408 |
| Sex (female) | 0.290 | 0.105 | 0.798 | 0.017 |
| Age | 1.049 | 1.001 | 1.098 | 0.048 |
| Size of the Femoral Component | 0.948 | 0.848 | 1.060 | 0.349 |
| Clinical Diagnosis | 0.060 | |||
| Osteonecrosis vs. OAa | 0.154 | 0.034 | 0.698 | 0.015 |
| Rheumatoid Arthritis vs. OAa | 0.656 | 0.117 | 3.684 | 0.632 |
| Posttraumatic Arthritis vs. OAa | 4.798 | 0.481 | 47.889 | 0.182 |
| Hip Dysplasia vs. OAa | 0.568 | 0.180 | 1.794 | 0.335 |
aprimary osteoarthritis
Logistic regression analysis and a global F test (for clinical diagnosis).
Osteonecrosis in retrieved hip resurfacing arthroplasty
| OR | 95% CI for OR | Significance | ||
|---|---|---|---|---|
| Lower | Upper | ( | ||
| Sex (female) | 0.507 | 0.201 | 1.280 | 0.151 |
| Size of the Femoral Component | 0.978 | 0.883 | 1.084 | 0.676 |
| Sex (female) | 0.159 | 0.040 | 0.634 | 0.009 |
| Age | 1.010 | 0.952 | 1.072 | 0.738 |
| Size of the Femoral Component | 0.867 | 0.748 | 1.004 | 0.057 |
| Clinical Diagnosis | 0.579 | |||
| Osteonecrosis vs. OAa | 0.255 | 0.050 | 1.295 | 0.099 |
| Rheumatoid Arthritis vs. OAa | 1.352 | 0.129 | 14.135 | 0.801 |
| Posttraumatic Arthritis vs. OAa | n.e.b | - | - | - |
| Hip Dysplasia vs. OAa | n.e.b | - | - | - |
aprimary osteoarthritis; bnot estimable
Logistic regression analysis and a global F test (for clinical diagnosis)
Excessive lymphocyte infiltration of bone remnant tissue in retrieved hip resurfacing arthroplasty
| OR | 95% CI for OR | Significance | ||
|---|---|---|---|---|
| Lower | Upper | ( | ||
| Sex (female) | 11.600 | 1.451 | 92.731 | 0.021 |
| Size of the Femoral Component | 0.810 | 0.689 | 0.953 | 0.011 |
| Sex (female) | 10.216 | 0.787 | 132.574 | 0.076 |
| Age | 0.969 | 0.891 | 1.055 | 0.471 |
| Size of the Femoral Component | 0.971 | 0.779 | 1.210 | 0.792 |
| Clinical Diagnosis | 0.886 | |||
| Osteonecrosis vs. OAa | 3.546 | 0.288 | 43.597 | 0.323 |
| Rheumatoid Arthritis vs. OAa | 1.982 | 0.161 | 24.437 | 0.593 |
| Posttraumatic Arthritis vs. OAa | n.e.b | - | - | - |
| Hip Dysplasia vs. OAa | n.e.b | - | - | - |
aprimary osteoarthritis; bnot estimable
Logistic regression analysis and a global F test (for clinical diagnosis).
Hyperosteoidosis of the bone trabeculae at the bone-cement interface in retrieved hip resurfacing arthroplasty.
| OR | 95% CI for OR | Significance | ||
|---|---|---|---|---|
| Lower | Upper | ( | ||
| Sex (female) | 3.492 | 1.457 | 8.368 | 0.005 |
| Size of the Femoral Component | 0.918 | 0.836 | 1.009 | 0.076 |
| Sex (female) | 4.190 | 1.142 | 15.376 | 0.031 |
| Age | 0.496 | 0.928 | 1.037 | 0.471 |
| Size of the Femoral Component | 1.003 | 0.876 | 1.037 | 0.961 |
| Clinical Diagnosis | 0.733 | |||
| Osteonecrosis vs. OAa | 2.909 | 0.586 | 14.430 | 0.191 |
| Rheumatoid Arthritis vs. OAa | n.e.b | - | - | - |
| Posttraumatic Arthritis vs. OAa | n.e.b | - | - | - |
| Hip Dysplasia vs. OAa | 0.771 | 0.180 | 3.312 | 0.727 |
aprimary osteoarthritis; bnot estimable
Logistic regression analysis and a global F test (for clinical diagnosis).